Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

ClinicalTrials.gov ID: NCT00696436

Public ClinicalTrials.gov record NCT00696436. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 4:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled, 5-Arm Titration Study to Evaluate the Efficacy and Safety of TAK-491 When Compared With Valsartan and Olmesartan in Subjects With Essential Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil, once daily (QD), compared to placebo, valsartan and olmesartan in participants with essential hypertension.

Study identification

NCT ID
NCT00696436
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
1,291 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2008 (Type not available)
Primary completion
Aug 2009 (Actual)
Completion
Aug 2009 (Actual)
Last update posted
Apr 19, 2011

2008 – 2009

United States locations

U.S. sites
86
U.S. states
26
U.S. cities
86
Facility City State ZIP Site status
Not listed Alabaster Alabama — —
Not listed Ozark Alabama — —
Not listed Green Valley Arizona — —
Not listed Litchfield Park Arizona — —
Not listed Mesa Arizona — —
Not listed Tempe Arizona — —
Not listed Carmichael California — —
Not listed Chula Vista California — —
Not listed Lincoln California — —
Not listed Mission Viejo California — —
Not listed National City California — —
Not listed Pasadena California — —
Not listed Riverside California — —
Not listed Sacramento California — —
Not listed San Diego California — —
Not listed San Dimas California — —
Not listed San Francisco California — —
Not listed San Ramon California — —
Not listed Santa Ana California — —
Not listed Vista California — —
Not listed Colorado Springs Colorado — —
Not listed Denver Colorado — —
Not listed Littleton Colorado — —
Not listed Longmont Colorado — —
Not listed Cape Coral Florida — —
Not listed Clearwater Florida — —
Not listed Largo Florida — —
Not listed Miami Florida — —
Not listed New Port Richey Florida — —
Not listed New Smyrna Beach Florida — —
Not listed Palm Harbor Florida — —
Not listed Tallahassee Florida — —
Not listed Dunwoody Georgia — —
Not listed Roswell Georgia — —
Not listed Arlington Heights Illinois — —
Not listed Belleville Illinois — —
Not listed Champaign Illinois — —
Not listed Chicago Illinois — —
Not listed Peoria Illinois — —
Not listed Vernon Hills Illinois — —
Not listed Evansville Indiana — —
Not listed Indianapolis Indiana — —
Not listed Terre Haute Indiana — —
Not listed Kansas City Kansas — —
Not listed Overland Park Kansas — —
Not listed Shawnee Kansas — —
Not listed Biddeford Maine — —
Not listed Norwood Maine — —
Not listed Baltimore Maryland — —
Not listed Towson Maryland — —
Not listed Brooklyn Center Minnesota — —
Not listed Chesterfield Missouri — —
Not listed Jefferson City Missouri — —
Not listed Kansas City Missouri — —
Not listed St Louis Missouri — —
Not listed Billings Montana — —
Not listed Las Vegas Nevada — —
Not listed Margate City New Jersey — —
Not listed Glens Falls New York — —
Not listed Great Neck New York — —
Not listed New Hyde Park New York — —
Not listed New Windsor New York — —
Not listed New York New York — —
Not listed Charlotte North Carolina — —
Not listed Raleigh North Carolina — —
Not listed Columbus Ohio — —
Not listed Norman Oklahoma — —
Not listed Tulsa Oklahoma — —
Not listed Yukon Oklahoma — —
Not listed Ashland Oregon — —
Not listed Eugene Oregon — —
Not listed Medford Oregon — —
Not listed Portland Oregon — —
Not listed Pittsburgh Pennsylvania — —
Not listed Tipton Pennsylvania — —
Not listed Charleston South Carolina — —
Not listed Murrells Inlet South Carolina — —
Not listed North Charleston South Carolina — —
Not listed Cleveland Tennessee — —
Not listed Bedford Texas — —
Not listed Dallas Texas — —
Not listed Houston Texas — —
Not listed Missouri City Texas — —
Not listed San Antonio Texas — —
Not listed Sugarland Texas — —
Not listed Tacoma Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00696436, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 19, 2011 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00696436 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →